|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-5-29
|
|
pubmed:abstractText |
The role of adjuvant chemoradiation therapy (CRT) in pancreatic cancer remains controversial. The primary aim of this study was to determine if CRT improved survival in patients with resected pancreatic cancer in a large, multiinstitutional cohort of patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1879-1190
|
|
pubmed:author |
pubmed-author:AhmadSyed ASA,
pubmed-author:AyersG DanielGD,
pubmed-author:BednarskiBrian KBK,
pubmed-author:CastellanosJasonJ,
pubmed-author:ChoClifford SCS,
pubmed-author:ChuCarrie KCK,
pubmed-author:KimHong JinHJ,
pubmed-author:KoehlerElizabeth A SEA,
pubmed-author:KoobyDavid ADA,
pubmed-author:MartinRobert C GRC,
pubmed-author:MatosJesus MJM,
pubmed-author:McClaineRebeccaR,
pubmed-author:MerchantNipun BNB,
pubmed-author:NakeebAtillaA,
pubmed-author:ParikhAlexander AAA,
pubmed-author:RymerJenniferJ,
pubmed-author:SchmidtC MaxCM,
pubmed-author:ScogginsCharles RCR,
pubmed-author:SharpKennethK,
pubmed-author:StaleyCharles ACA,
pubmed-author:WeberSharon HSH
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
208
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
829-38; discussion 838-41
|
|
pubmed:meshHeading |
pubmed-meshheading:19476845-Adenocarcinoma,
pubmed-meshheading:19476845-Aged,
pubmed-meshheading:19476845-Chemotherapy, Adjuvant,
pubmed-meshheading:19476845-Disease-Free Survival,
pubmed-meshheading:19476845-Female,
pubmed-meshheading:19476845-Humans,
pubmed-meshheading:19476845-Lymphatic Metastasis,
pubmed-meshheading:19476845-Male,
pubmed-meshheading:19476845-Middle Aged,
pubmed-meshheading:19476845-Pancreatic Neoplasms,
pubmed-meshheading:19476845-Proportional Hazards Models,
pubmed-meshheading:19476845-Radiotherapy, Adjuvant,
pubmed-meshheading:19476845-Survival Analysis
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits?
|
|
pubmed:affiliation |
Department of Surgery, Vanderbilt University Medical Center, Nashville, TN 37232-6860, USA.
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|
